Focus on the anti-inflammatory effect of glucocorticosteroids in experimental acute lung injury
- Authors: Voloshin N.I.1, Zamiralova Y.A.1, Pugach V.A.2, Salukhov V.V.1, Tyunin M.A.2, Kharitonov M.A.1, Odintsova I.A.1, Slizhov P.A.1, Minakov A.A.1, Slutskaya D.R.1
-
Affiliations:
- Military Medical Academy
- State Scientific Research Test Institute of the Military Medicine
- Issue: Vol 42, No 2 (2023)
- Pages: 167-176
- Section: Original articles
- URL: https://bakhtiniada.ru/RMMArep/article/view/316031
- DOI: https://doi.org/10.17816/rmmar456457
- ID: 316031
Cite item
Abstract
AIM: Assessment of the effect of various doses of dexamethasone as an inflammation modulator in experimental lipopolysaccharide-induced acute lung injury in rats.
MATERIALS AND METHODS: Acute lung injury in rats was modeled by intratracheal administration of cell wall lipopolysaccharide from the Salmonella enterica. White male rats were divided into groups: a group of intact animals (n = 10); the control group (n = 40), in which the animals were simulated acute lung injury without further treatment and removed from the experiment on day 3; three experimental groups (n = 40), in which, 3 hours after modeling acute lung injury, and then daily once a day for 3 days, dexamethasone solution was administered intraperitoneally in the following doses: in group 1 — 0.52 mg/kg (equivalent to 6.0 mg/day for a person), in group 2 — 1.71 mg/kg (20.0 mg/day for a person), in group 3 — 8.0 mg/kg (94.0 mg/day, pulse therapy for humans). On the 3rd day, blood samples were taken from the caudal vena cava in surviving animals for clinical analysis and evaluation of the function of mitochondria of peripheral blood leukocytes. To determine the severity of local inflammatory reactions and pulmonary edema, bronchoalveolar lavage was performed with the study of an endopulmonary cytogram and an assessment of pathomorphological changes in the lung tissue.
RESULTS: indicate that dexamethasone reduces the amount of lung tissue damage and animal mortality, dose-dependently reduces the functions of mitochondria and the number of lymphocytes and monocytes in peripheral blood, as well as neutrophils, lymphocytes and macrophages in bronchoalveolar lavage samples.
CONCLUSION: The use of dexamethasone at a dose of 0.52 mg/kg (equivalent to 6.0 mg/day for humans) is accompanied by better survival, minimal effect on the viability and functional activity of inflammatory cells. Pulse therapy leads to a significant decrease in the number of immunocompetent cells in bronchoalveolar lavage, mitochondrial dysfunction in the form of a decrease in the ability of these cells to use the reserve power of mitochondrial respiration in response to the action of a stress factor. Excessive inhibition of immunocompetent cells can contribute to the activation of latent and opportunistic infections, which must be taken into account when choosing a dosing regimen for glucocorticosteroids.
Full Text
##article.viewOnOriginalSite##About the authors
Nikita I. Voloshin
Military Medical Academy
Author for correspondence.
Email: nikitavoloshin1990@gmail.com
ORCID iD: 0000-0002-3880-9548
SPIN-code: 6061-4342
Scopus Author ID: 57926549500
ResearcherId: HSG-7925-2023
M.D., postgraduate student of Therapy of Doctors Improvement Department
Russian Federation, Saint PetersburgYuliya A. Zamiralova
Military Medical Academy
Email: yulia_nikolaeva@hotmail.com
ORCID iD: 0009-0000-5631-9932
SPIN-code: 7692-9410
ResearcherId: HSG-9775-2023
student
Russian Federation, Saint PetersburgVictoriya A. Pugach
State Scientific Research Test Institute of the Military Medicine
Email: gniiivm_7@mil.ru
ORCID iD: 0000-0003-4290-350X
SPIN-code: 3739-3699
Scopus Author ID: 57195201128
ResearcherId: ACD-0418-2022
Ph.D. (Biology), Senior researcher
Russian Federation, Saint PetersburgVladimir V. Salukhov
Military Medical Academy
Email: vlasaluk@yandex.ru
ORCID iD: 0000-0003-1851-0941
SPIN-code: 4531-6011
Scopus Author ID: 55804184100
M.D., D.Sc. (Medicine), Associate Professor, the Head of Therapy of Doctors Improvement the first Department
Russian Federation, Saint PetersburgMikhail A. Tyunin
State Scientific Research Test Institute of the Military Medicine
Email: gniiivm_7@mil.ru
ORCID iD: 0000-0002-6974-5583
SPIN-code: 6161-7029
Scopus Author ID: 25032311600
M.D., Ph.D. (Medicine), deputy Head of the center
Russian Federation, Saint PetersburgMikhail A. Kharitonov
Military Medical Academy
Email: micjul11@yandex.ru
ORCID iD: 0000-0002-6521-7986
SPIN-code: 7678-2278
Scopus Author ID: 57521284600
ResearcherId: H-6056-2015
M.D., D.Sc. (Medicine), Professor, the Therapy of Doctors Improvement the first Department
Russian Federation, Saint PetersburgIrina A. Odintsova
Military Medical Academy
Email: odintsova-irina@mail.ru
ORCID iD: 0000-0002-0143-7402
SPIN-code: 1523-8394
Scopus Author ID: 6603745712
ResearcherId: 96874
D.Sc. (Biology), Professor, the Head of the Histology with a Course in Embryology Department
Russian Federation, Saint PetersburgPavel A. Slizhov
Military Medical Academy
Email: maidel@bk.ru
ORCID iD: 0000-0001-6885-5273
SPIN-code: 3626-6262
Scopus Author ID: 57203389614
ResearcherId: X-5497-2018
junior researcher of the Department (experimental medicine) of the Research Center
Russian Federation, Saint PetersburgAleksey A. Minakov
Military Medical Academy
Email: minacom@mail.ru
ORCID iD: 0000-0003-1525-3601
SPIN-code: 5344-7883
Scopus Author ID: 57926549400
ResearcherId: HSG-9445-2023
M.D., postgraduate student of Therapy of Doctors Improvement the first Department
Russian Federation, Saint PetersburgDina R. Slutskaya
Military Medical Academy
Email: dina_hanieva@mail.ru
ORCID iD: 0000-0003-3910-2621
SPIN-code: 2546-9393
ResearcherId: 882535
Ph.D. (Biology), Associate Professor, the teacher of Histology with a Course in Embryology Department
Russian Federation, Saint PetersburgReferences
- Edalatifard M, Akhtari M, Salehi M, et. al. Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial. Eur Respir J. 2020;56(6):2002808. doi: 10.1183/13993003.02808-2020
- Stolz E, Klötzsch C, Schlachetzki F, et. al. High-dose corticosteroid treatment is associated with an increased risk of developing cerebral venous thrombosis. Eur Neurol. 2003;49(4):24–78. doi: 10.1159/000070197
- Munch MW, Myatra SN, Vijayaraghavan B, et. al. Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID2 Randomized Trial. JAMA. 2021;326(18):1807–1817. doi: 10.1001/jama.2021.18295
- Yaroshetskiy AI, Gritsan AI, Avdeev SN, et. al. Diagnostics and intensive therapy of Acute Respiratory Distress Syndrome Russian. (Clinical guidelines of the Federation of Anesthesiologists and Reanimatologists of Russia). Russian Journal of Anаеsthesiology and Reanimatology. 2020;(2):5–39. (In Russ.) doi: 10.17116/anaesthesiology20200215
- Fan E, Del Sorbo L, Goligher EC, et. al. An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2017;195(9):1253–1263. doi: 10.1164/rccm.201703-0548ST
- Matute-Bello G, Downey G, Moore BB, et. al. Acute Lung Injury in Animals Study Group. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol. 2011;44(5):725–738. doi: 10.1165/rcmb.2009-0210ST
- Lin S, Wu H, Wang C, et. al. Regulatory T Cells and Acute Lung Injury: Cytokines, Uncontrolled Inflammation, and Therapeutic Implications. Front Immunol. 2018;9:1545. doi: 10.3389/fimmu.2018.01545
- Salukhov VV, Kharitonov MA, Kryukov EV, et. al. Topical issues of diagnostics, examination and treatment of patients with COVID-19-associated pneumonia in different countries and continents. Meditsinskiy sovet 2020;(21):96–102. (In Russ.) doi: 10.21518/2079-701X-2020-21-96-102
- Salukhov VV, Voloshin NI, Shperling MI. Effectiveness of various regimens of systemic anti-inflammatory therapy with glucocorticoids in the development of acute LPS-induced lung damage in the experiment. Russian Military Medical Academy Reports. 2022;41(2):111–116. (In Russ.) doi: 10.17816/rmmar104619
- Griffiths M, McAuley D, Perkins G, et. al. Guidelines on the management of acute respiratory distress syndrome. BMJ Open Respir Res. 2019;6(1):e000420. doi: 10.1136/bmjresp-2019-000420
- Shekunova EV, Kovaleva MA, Makarova MN, et. al. The choice of dose of the drug for preclinical studies: interspecies transfer of doses. Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo primeneniya. 2020;10(1):19–28 (In Russ.) doi: 10.30895/1991-2919-2020-10-1-19-28
- Ince LM, Weber J, Scheiermann C. Control of Leukocyte Trafficking by Stress-Associated Hormones. Front Immunol. 2019;9:3143. doi: 10.3389/fimmu.2018.03143
- Qin M, Qiu Z. Changes in TNF-α, IL-6, IL-10 and VEGF in rats with ARDS and the effects of dexamethasone. Exp Ther Med. 2019;17(1):383–387. doi: 10.3892/etm.2018.6926
Supplementary files
